Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion

Vertex Pharmaceuticals has announced its acquisition of Crinetics Pharmaceuticals in a deal valued at $10 billion. This marks Vertex's largest acquisition to date, expanding its portfolio in the pharmaceutical sector.

6 Jul, 20:18 — 6 Jul, 20:18

Post Share

Sources

Showing 1 of 2 sources

bloombergHigh38d ago

Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet - Bloomberg.com

Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet Bloomberg.com

Read full article →

Coverage Timeline

First report: bloomberg · 6 Jul, 20:18|Full coverage: 2 · 3m|Window: 3m

Left-leaningCenterRight-leaning

bloomberg6 Jul, 20:18First to report

Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet - Bloomberg.com

seeking-alpha6 Jul, 20:21Latest update

PERSPECTA

PERSPECTA

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion

Sources

Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet - Bloomberg.com

Coverage Timeline

Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet - Bloomberg.com

Vertex to acquire Crinetics Pharmaceuticals in $10B deal

Related Stories

Jeff Bezos Consortium Acquires 30% Stake in Liverpool FC

Uber Plans to Deploy 2,000 Robotaxis in Europe

Belgian Students Discover €9 Million Gold Stash in House

Former Moldovan MP Denies Bribery Allegations in Metal Waste Market

PERSPECTA